Skip to main content

Table 4 Key characteristics of participants without legal system involvement, participants who were only victims of crime, and perpetrators who were not victims of crime.

From: Involvement in the US criminal justice system and cost implications for persons treated for schizophrenia

Variable

A

Patients without any legal involvement

N = 331

B

Patients who were only victims of crime

N = 113

C

Perpetrator who were not victims of crime

N = 91

P-value

Unadjusted, overall group comparison

(A vs B vs C)

P-value

Adjusted for covariates, overall group comparison

(A vs B vs C)

P-value

Adjusted for covariates, Victims VS Perpetrators

(B vs C)

Age, mean (SD)

44.5 (12.1)

44.3 (11.1)

40.0 (12.0)

0.005

0.024

0.066

Male gender, n (%)

200 (60%)

57 (50%)

63 (69%)

0.023

0.046

0.016

Ethnicity -- Caucasian, n (%)

185 (56%)

69 (61%)

45 (49%)

0.566

0.646

0.333

   -African-American, n (%)

109 (33%)

33 (29%)

36 (36%)

   

   -Other ethnic group, n (%)

37 (11%)

11 (10%)

13 (14%)

   

Uninsured, n (%)

48 (15%)

13 (12%)

25 (28%)

0.006

0.132

0.074

PANSS total, mean (SD)

86.9 (21.2)

86.9 (18.2)

84.8 (19.0)

0.659

0.648

0.482

SF36 MCS, mean (SD)

-0.85 (1.31)

-1.23 (1.33)

-1.10 (1.32)

0.018

0.025

0.275

SF36 PCS, mean (SD)

-0.40 (1.02)

-0.55 (1.14)

-0.39 (1.00)

0.372

0.366

0.990

Past year psych hospitalization None, n (%)

245 (75%)

79 (73%)

53 (60%)

0.016

0.167

0.714

ER past 3 months, n (%)

76 (24%)

32 (29%)

30 (33%)

0.146

0.257

0.454

Lifetime diagnosis of substance use disorder, n (%)

117 (35%)

51 (45%)

45 (49%)

0.024

0.032

0.837

Use of alcohol to intoxication, n (%)

19 (6%)

7 (6%)

9 (10%)

0.362

0.547

0.547

Any use of cannabis, n (%)

19 (6%)

15 (13%)

20 (22%)

< 0.001

< 0.001

0.466

Any use of cocaine, n (%)

6 (2%)

4 (4%)

8 (9%)

0.005

0.018

0.242

MPR ≥ 80%, n (%)

146 (50%)

47 (46%)

28 (34%)

0.042

0.195

0.513

MPR, mean (SD)

0.60 (0.42)

0.53 (0.44)

0.42 (0.44)

0.004

0.023

0.520

Discontinued study, n (%)

72 (22%)

30 (27%)

28 (31%)

0.170

0.294

0.820

Mean days to study discontinuation, mean (SD)

325.3 (84.2)

310.1 (96.0)

312.1 (99.7)

0.200

0.207

0.587